ABFAX | RLBEX | ABFAX / RLBEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 23 years | - |
Gain YTD | 2.340 | 3.064 | 76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 110M | 242B | 0% |
Annual Yield % from dividends | 1.83 | 2.24 | 82% |
Returns for 1 year | 3.42 | 12.44 | 27% |
Returns for 3 years | -3.26 | 15.91 | -21% |
Returns for 5 years | -4.77 | 31.69 | -15% |
Returns for 10 years | -6.54 | 58.21 | -11% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 53.51 | 0.47 | +0.89% |
ProShares Ultra Nasdaq Biotechnology | |||
ELQD | 79.20 | N/A | N/A |
iShares ESG Advanced Inv Grd Corp Bd ETF | |||
JVAL | 44.97 | -0.02 | -0.04% |
JPMorgan US Value Factor ETF | |||
EMBD | 22.73 | -0.02 | -0.09% |
Global X Emerging Markets Bond ETF | |||
DFCF | 41.31 | -0.08 | -0.19% |
Dimensional Core Fixed Income ETF |